AB Science publishes study showing masitinib survival benefits in ALS patients
Go back to AB Science publishes study showing masitinib survival benefits in ALS patients| ALLIANCEBERNSTEIN HOLDING, L.P. (NYSE: AB) | Delayed: 35.16 -0.62 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.78 | 52 Week High | $26.24 | |||
| Open | $35.64 | 52 Week Low | $16.11 | |||
| Day High | $35.83 | P/E | 20.68 | |||
| Day Low | $34.92 | EPS | $1.70 | |||
| Volume | 611,626 | |||||
